Adimmune

Adimmune visited by Executive Yuan, promises to deliver COVID-19 vaccine

Adimmune Biotech Corporation(4142), today welcomed the scie

COVID-19 Epidemic drives demand for influenza vaccine

Adimmune Biotech Corporation(4142) April revenue came in at

COVID-19 Vaccine proven effective, Adimmune COVID-19 vaccine antibody response is excellent

When the COVID-19 epidemic first broke out in January 2020,

Adimmune’s new COVID-19 vaccine clinical trials confirms vaccine effectiveness

Adimmune Biotech Corporation(4142) announced today, Adimmun

Adimmune strives to turn losses into profit this year, as profit margins turn from negative to positive

Adimmune Biotech Corporation(4142) announced today that rev

AIT visit Adimmune

Adimmune production line expansion on schedule and will accelerate COVID-19 vaccine development

Adimmune Biotech Corporation(4142), announced today that Fe

Adimmune collaborates with the Taiwanese National Health Research Institute to accelerate research for Covid-19 vaccine

In order to assist the government in handling COVID-19, the

Adimmune Corporation monthly revenue hits new historical record again

Adimmune Biotech Corporation(4142), announced today that mo

Adimmune Board of Directors passes plan to construct new factory Initiating the construction of “All purpose biotech campus”

Adimmune(4142) Board of Directors passed a plan on January

Adimmune December revenue soars, Signs contract abroad

Adimmune's Quadrivalent Flu Vaccine Approved by TFDA

TAIPEI,Taiwan, May 10

Adimmune begins shipments to EU and Phase III trial in Europe

TAIPEI,Taiwan, Nov. 23, 2016 /PRNewswir

Adimmune Successfully Places NT$1.5 BN Guaranteed Convertible Bonds

TAIPEI,Taiwan, Oct. 21, 2016 /PRNewswir